CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such ...

While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious ...

Executives from Stryker and Johnson & Johnson are on the hunt for deals, despite a turbulent environment, they said at ...

With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on ...

Investment in 2025 has reached $9.9 billion, exceeding the $8.4 billion that was raised through the third quarter last year, ...

Companies creating new robotic platforms marked additional milestones heading into the fourth quarter. Catch up with their ...

The FDA cleared AI and imaging updates for Intuitive’s lung biopsy robot. Elsewhere, Horizon completed the first cataract ...

Michelle Tarver, director of the Center for Devices and Radiological Health, and other center officials attended virtually as ...

Six takeaways from the CMS administrator’s appearance at a D.C. think tank Monday — including who’s set to be the next ...

The sale will leave Owens & Minor focused on a smaller but potentially faster-growing and higher-margin business that ...

At AdvaMed’s annual conference, CEO Scott Whitaker addressed policy issues around tariffs, FDA staff cuts and the ongoing ...

After acquiring Paragon 28 earlier this year, Zimmer intends to maintain the foot and ankle specialist’s double-digit growth.